Sanara MedTech Inc. SMTI EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Sanara MedTech Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sanara MedTech Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sanara MedTech Inc.'s EPS (diluted)?
- Sanara MedTech Inc. (SMTI) reported EPS (diluted) of $0.05 in Q1 2026.
- How has Sanara MedTech Inc.'s EPS (diluted) changed year-over-year?
- Sanara MedTech Inc.'s EPS (diluted) increased by 112.2% year-over-year, from -$0.41 to $0.05.
- What is the long-term trend for Sanara MedTech Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Sanara MedTech Inc.'s EPS (diluted) has grown at a 41.7% compound annual growth rate (CAGR), from -$1.08 to -$4.36.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.